Success Stories: EB-1A Approved for Biogeochemistry Research Associate in Illinois in the Field of Ecology

Client’s Testimonial:

I do not know how to thank you and your team. I am confident in your skills and expertise and trusted your confidence. Chen immigration=100% success, this is the formula. I am very happy, that my both petitions were approved with your great and meticulous help. Without your assistance, this [wouldn’t] have possible today. I believe, your expertise played a vital role than my credentials itself. I trusted your meticulous skills and great expertise. I thank you all from my bottom of my heart. Even before I got the approval notice, I have already placed my highest recommendation in Linkedin, this is my confidence and trust on you. You deserve the best accolades and recommendation. One of the best decision that I made in my life is, I came to you for green card filing. You are the best attorney in the country. Very honest, financially flexible, time keeping, service-oriented, not money minded, very helping and devoted attorney. God bless you.

On May 7^th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Biogeochemistry Research Associate in the Field of Ecology (Approval Notice)

General Field: Ecology

Position at the Time of Case Filing: Biogeochemistry Research Associate

Country of Origin: India

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Illinois

Approval Notice Date: May 7, 2014

Processing Time: 4 month, 7 days

Case Summary:

The client that we had the pleasure of working with in this case was a Biogeochemistry Research Associate from India in the field of ecology. His strong background in ecology, environmental sciences, biology, biogeochemistry, and analytical techniques had allowed his research to be particularly original, with applications such as informing future decisions regarding how we as a nation and as a planet plan to deal with the progressing climate changes that are affecting important crops and ecosystems all over the world. His work had resulted in 16 peer-review articles, 3 book chapters, 4 research papers in reputed journals of South Asia, and numerous conference papers. At the time that his case was filed, his publications been cited at least 318 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. In addition, he had reviewed 16 manuscripts for distinctive, internationally-circulated journals related to his field. The expansive significance of his work was confirmed in the following quote from an independent recommender, “Though much of his work I am best familiarized with is centralized in Europe (including similar work carried out in Portugal), [his] research extends to the global scale. For example, he is presently working in the United States, performing research on the production of corn, and the drought impacts on these and other type of crops used as new biofuels. Heavily industrialized nations, such as the United States and others, are currently implementing the most efficacious biofuel source cultivation and methods, and [his] work is greatly assisting in the positive outcome of this progress.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought remain in the United States to continue work in the area of extraordinary ability, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 4 months and 7 days.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.